MedTrace Logo

A Validation Study to Evaluate the Performance of Caption Health Lung Guidance and Interpretation

NCT05992324 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 220

Last updated 2024-11-26

No results posted yet for this study

Summary

The purpose of this study is to assess the efficacy of Caption LungAI.

Conditions

Interventions

DEVICE

Caption LungAI

Caption LungAI is a software that is designed to help non-expert healthcare professionals acquire diagnostic quality images on an 8-zone lung protocol for both healthy patients and patients presenting with pathology such as B-Lines.

Sponsors & Collaborators

  • Caption Health, Inc.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-17
Primary Completion
2024-12-31
Completion
2025-03-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05992324 on ClinicalTrials.gov